Related Experiment Videos
[Surgery after neo-adjuvant therapy of non-small cell lung cancer. Preliminary results]
U Mercati1, P Fiaschini, S Darwish
1Unità di Chirurgia, Ospedale R. Silvestrini, Perugia.
Minerva Chirurgica
|September 15, 1991
Abstract:
The Authors report their personal experience of surgical treatment following neo-adjuvant therapy in NSCLC (III a N2) in order to assess: 1) the feasibility and safety of surgical treatment following major responses to neoadjuvant chemotherapy; 2) the sectile rate; and 3) the survival rate. Preliminary results show that: 1) chemotherapy using cisplatin and VP-16 gives a high rate of major responses in these patients; 2) surgery is feasible; 3) there is high radical sectile rate; 4) further research is needed to obtain statistical significance.